Castella Imports Inc. is one of the largest importers of specialty foods in the United States. “Through hard work and dedication, Castella offers the highest quality products, which exceed industry standards, with unsurpassed packaging, pricing and distribution,” President and owner Bill Valsamos says. The Hauppauge, N.Y.- based firm provides a variety of products such as antipastos, beverages, bread crumbs, bruschettas, cheeses, flavors, food colors, olives, olive oils, sauces, specialty foods, spices, vegetables and vinegar.

As a manufacturer and distributor, “Castella has the passion for being the link to [other countries],” Valsamos says. “We work with the best growers in Chile, France, Greece, Morocco, Peru, Spain, Turkey and here in the United States to ensure our tradition of quality, freshness and variety.”

Castella has a long-standing reputation with its vendors. “We evolve and expand with the partnerships of our vendors, such as Rez-Tech,” Vice President Chris Valsamos says.

“Castella has achieved something that not many companies have, which is continued growth during a down [economy],” Bill Valsamos adds. “As of 2000, we’ve doubled sales every five years.”

Customer Feedback

Diversity is one way the company has been able to set itself apart. “By expanding into new markets, such as supermarkets and Costco, we have extended our expertise and developed new, authentic items,” Valsamos says. “We embrace the challenge of research and development.”

Staying on top of customers’ tastes and industry trends is a priority for Castella Imports. “We do a road show on a weekly basis at Costco,” Chris Valsamos says. “With that, we’re able to work with [customers] on a one-on-one basis. Castella anticipates and responds to culinary trends.”

Later this year, the company will introduce wine-infused olives to the market with its Castella Vineyard Collection. It will feature flavors such as chardonnay and merlot. Samples of the new line were given to customers and the feedback has been outstanding, he says.

Product packaging is a key factor for Castella. “The right packaging can benefit the customer in a multitude of ways,” Valsamos says. “For example, we had glass [packaging], but now we have plastic and plastic bags to bring down freight costs.” Castella transports its products nationwide with its own trucks. “We developed our own fleet of trucks so we can deliver merchandise for a reduced freight rate,” he says. “That is one of our competitive edges.”

One-Stop Shop

Castella’s products distinguish it from the rest of its competitors in the industry. “We have a large array of products,” Bill Valsamos says. “Our multitude of product lines gives us the advantage in the industry,” Chris Valsamos adds. “Companies that offer a single product line find it difficult to compete with Castella.”

Distributors can purchase products directly from the company, which is also different from most firms, Bill Valsamos says. “If a distributor has 10 vendors and they need 10,000 each, they can buy all those products from us,” he says.

“With that, we refer to ourselves as a one-stop shop, or your global marketplace,” Chris Valsamos explains.

Growth Factor

In 1992, the roots of the company began in a production facility in Hicksville, N.Y. By 1999, the company doubled and relocated to Farmingdale. “To keep up with the demands of our customers, we opened our own distribution center in Wood Dale, Ill., in 2002,” Bill Valsamos says.

Castella acquired Millflow Spice Corp. and Regal Extract Co. in 2003. “This acquisition made us one of the largest spice companies in the Northeast,” Chris Valsamos adds.

A year later, Castella acquired the assets of Salvati Food, one of the largest Italian specialty manufacturers in the United States. Later that year, the company acquired and built its current 3.5 million-cubic-foot, state-of-the-art warehouse in Hauppauge.

Growth will continue to be the company’s major focus. Moving forward, “Castella will expand its nationwide delivery program by opening warehouses in Atlanta, Houston and Los Angeles,” Chris Valsamos says.

“Keeping in mind our customers’ desire for healthier and more delicious foods, Castella will continue to set the standard for the food industry through innovation and quality,” he adds.

Check out our latest Edition!



  • LONDON, 29 May. 2020 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire.

  • CAMBRIDGE, Mass., May 28, 2020 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (Nasdaq:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced the pricing of an underwritten public offering of 8,000,000 shares of common stock at a price to the public of $19.00 per share. Gross proceeds to Mersana from the offering are expected to be $152.0 million, before deducting underwriting discounts and commissions and offering expenses payable by Mersana. In addition, Mersana has granted the underwriters a 30-day option to purchase up to an additional 1,200,000 shares of common stock, at the public offering price less underwriting discounts and commissions. All shares are being sold by Mersana. The offering is expected to close on June 2, 2020, subject to the satisfaction of customary closing conditions.

  • Dallas Criminal Defense Attorneys Broden Mickelsen review a recent ruling of the Texas Court of Criminal Appeals, which granted a 60-day on the execution of a convicted triple murderer due to COVID-19.
    Dallas Criminal Defense Attorneys Broden Mickelsen review a recent ruling of the Texas Court of Criminal Appeals, which granted a 60-day on the execution of a convicted triple murderer due to COVID-19.
  • TORONTO, May 28, 2020 (GLOBE NEWSWIRE) -- Itafos (TSX-V: IFOS) (the “Company”) reported today its Q1 2020 financial results and operational highlights. The Company’s financial statements and management’s discussion and analysis for the three months ended March 31, 2020 are available under the Company’s profile at and on the Company’s website at All dollar values are in thousands of US Dollars except as otherwise noted.

  • SAN CARLOS, Calif., May 28, 2020 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (Nasdaq:IOVA) (“Iovance” or “Company”), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies (tumor-infiltrating lymphocyte, TIL, and peripheral-blood lymphocyte, PBL), today announced the pricing of an underwritten public offering of 16,935,484 shares of its common stock at a public offering price of $31.00 per share.  The gross proceeds from the offering, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by Iovance, are expected to be approximately $525 million.  In addition, Iovance has granted the underwriters a 30-day option to purchase up to 2,540,322 additional shares of common stock at the public offering price, less the underwriting discounts and commissions.  The offering is expected to close on or about June 2, 2020, subject to customary closing conditions.

Contact Us

Food and Drink Magazine
150 N. Michigan Ave., Suite 900
Chicago, IL 60601


Click here for a full list of contacts.

Latest Edition

Spread The Love

Back To Top